值得注意的是，卧安机器人本月初携家庭场景落地的人形具身机器人onero H1、全球首款AI网球机器人 Acemate、AI陪伴机器人Kata Friends等全矩阵重磅亮相CES 2026，凭借硬核实力斩获多项国际权威奖 项。中信建投此前表示，中长期看，卧安机器人以"家庭AI具身机器人系统"作为底座，通过多品类矩阵 +App生态+全球渠道形成复购与规模效应，建议持续关注AI时代下公司创新+生态共振带来的成长空 间。 智通财经APP获悉，卧安机器人(06600)盘中涨超23%，再创上市新高。截至发稿，涨20.13%，报186.2 港元，成交额6169.85万港元。 公开资料显示，卧安机器人是家庭机器人系统全球提供商，主要市场包括日本、欧洲及北美，并致力于 构建以智慧家庭机器人产品为核心的生态系统。根据弗若斯特沙利文报告，按2024年的零售额计算，公 司在家庭机器人系统提供商中排名全球第一，市场份额为11.9%，亦为全球领先的家庭机器人系统提供 商，提供专为多种家庭生活场景设计的广泛家庭机器人品类。 ...

每经AI快讯，卧安机器人(06600.HK)一度涨超5%，截至发稿，涨4.38%，报155港元，成交额5213.51万 港元。 ...

Group 1 - The core viewpoint of the article highlights the significant stock price increase of Woan Robotics (06600), which has risen over 5% to a peak of 156.2 HKD, doubling from its IPO price of 73.8 HKD [1] - As of the report, the stock is trading at 155 HKD with a transaction volume of 52.1351 million HKD, indicating strong market interest [1] - Woan Robotics recently launched the humanoid embodied AI robot "onero" at CES, designed specifically for real family scenarios, marking a significant product innovation [1] Group 2 - The company has also introduced the world's first AI tennis training robot, Acemate, at the Shenzhen Baoan Super Network Center, providing training assistance for sports enthusiasts [1] - According to CITIC Securities, Woan Robotics is a leading provider of AI embodied home robot systems, with strong revenue growth momentum and expected profitability by 2025, indicating a new phase of scale expansion and profit release [1] - The company aims to leverage a "home AI embodied robot system" as a foundation, creating a multi-category matrix, app ecosystem, and global channels to drive repeat purchases and scale effects, suggesting significant growth potential in the AI era [1]

Core Viewpoint - Woan Robotics (06600) has seen its stock price increase over 5%, reaching a high of 156.2 HKD, which is more than double its IPO price of 73.8 HKD, indicating strong market performance and investor interest [1] Group 1: Product Launches and Innovations - Woan Robotics recently launched the humanoid intelligent robot "onero" at CES, designed specifically for real family scenarios [1] - The company has also introduced the world's first AI tennis training robot "Acemate" at the Shenzhen Baoan Super Net Center, providing training assistance for sports enthusiasts [1] Group 2: Financial Performance and Growth Potential - According to CITIC Securities, Woan Robotics is a leading provider of AI embodied home robot systems, with strong revenue growth momentum [1] - The company is expected to achieve substantial profitability by 2025, marking the beginning of a new phase of scale expansion and profit release [1] Group 3: Strategic Vision and Market Position - Woan Robotics aims to establish a "home AI embodied robot system" as its foundation, leveraging a multi-category matrix, app ecosystem, and global channels to create repurchase and scale effects [1] - The company is recommended for continued observation due to the growth potential arising from innovation and ecosystem resonance in the AI era [1]

每经AI快讯，卧安机器人(06600.HK)盘中涨超6%，高见144.7港元，再创上市新高。截至发稿，卧安机 器人涨5.14%，报143.1港元，成交额4923.63万港元。 ...

卧安机器人(06600)盘中涨超6%，高见144.7港元，再创上市新高。截至发稿，涨5.14%，报143.1港元， 成交额4923.63万港元。 消息面上，近日，卧安机器人发布人形具身智能机器人onero，其为CES全球首发的家庭保姆机器人， 专为真实家庭场景打造。 此外，1月10日，全球首家机器人网球训练场——深圳宝安超网中心"云馆"试 运行，卧安机器人旗下AI网球机器人Acemate入驻，为运动爱好者提供陪练。 天风证券（601162）发布研报称，卧安机器人作为全球居家机器人系统行业的先行者，凭借在执行增强 型机器人及感知决策系统领域的深厚专利壁垒，已建立起覆盖全球90多个国家、连接超1,000万台设备 的领先品牌认知，成长为全球龙头。本次赴港上市募资将用于强化研发投入、扩张全球全渠道网络及加 强品牌推广，有望通过"智能单品→系统生态"的跨越，持续释放全球化增长潜力。该行指出，考虑到公 司仍处于快速成长期，当前估值有所低估。 ...

智通财经APP获悉，卧安机器人(06600)盘中涨超6%，高见144.7港元，再创上市新高。截至发稿，涨 5.14%，报143.1港元，成交额4923.63万港元。 天风证券发布研报称，卧安机器人作为全球居家机器人系统行业的先行者，凭借在执行增强型机器人及 感知决策系统领域的深厚专利壁垒，已建立起覆盖全球90多个国家、连接超1,000万台设备的领先品牌 认知，成长为全球龙头。本次赴港上市募资将用于强化研发投入、扩张全球全渠道网络及加强品牌推 广，有望通过"智能单品→系统生态"的跨越，持续释放全球化增长潜力。该行指出，考虑到公司仍处于 快速成长期，当前估值有所低估。 消息面上，近日，卧安机器人发布人形具身智能机器人onero，其为CES全球首发的家庭保姆机器人， 专为真实家庭场景打造。 此外，1月10日，全球首家机器人网球训练场——深圳宝安超网中心"云馆"试 运行，卧安机器人旗下AI网球机器人Acemate入驻，为运动爱好者提供陪练。 ...

Core Viewpoint - The inclusion of Naxitamab in the commercial insurance directory is a significant advancement for children suffering from rare diseases, showcasing the successful implementation of the Boao Lecheng policy by Guangzhou Pharmaceutical Morning Fei [3]. Group 1: Company Achievements - Guangzhou Pharmaceutical Morning Fei has successfully introduced nearly 30 innovative imported drugs and medical devices, most of which have been transformed for domestic use, bridging international products with local healthcare needs [4]. - The company has facilitated early access to Naxitamab, allowing patients to receive the drug 18 months ahead of its official domestic launch, with prices being only one-seventh of those in the United States [3][4]. Group 2: Policy Impact - The Boao Lecheng pilot policy has created a green channel for patients in China, enabling early and cost-effective access to foreign medications, particularly for rare diseases, which are a national focus due to their high development costs and pricing [4]. - The support from national commercial insurance significantly reduces the financial burden on families, making essential medications more affordable [4]. Group 3: Future Plans - The company plans to leverage zero tariffs and streamlined administrative processes under the free trade port policy to expand the introduction of quality drugs and medical devices, aiming to provide affordable medications for more patients with rare and severe diseases without the need to go abroad [5].

联交所已批准超额配发股份上市及买卖。超额配发股份预期于2026年1月29日(星期四)上午九时正开始 于联交所主板上市及买卖。 此外，根据香港法例第571W章证券及期货(稳定价格)规则第9(2)条，公司宣布，有关全球发售的稳定价 格期间已于2026年1月22日(星期四)(即提交香港公开发售申请的截止日期后第30日)结束。 超额配发股份将由公司按每股股份73.80港元(即全球发售项下每股股份的发售价，不包括1%经纪佣金、 0.0027%证监会交易徵费、0.00565%联交所交易费及 0.00015%会财局交易徵费)发行及配发。超额配发 股份将用于促成向已同意延迟交付其根据全球发售于国际发售中认购的部分H股的承配人交付相关H 股。公司将自发行超额配发股份收取额外所得款项净额约2.25亿港元(经扣除公司就部分行使超额配股 权应付的包销费用以及佣金及估计开支)。 卧安机器人(06600)发布公告，公司宣布，招股章程所述的超额配股权已于2026年1月22日(星期四)获整 体协调人(为其本身及代表国际包销商)部分行使，涉及合共313.38万股股份(超额配发股份)，约占于任 何超额配股权获行使前全球发售项下初步可供认购的发售 ...

此外，根据香港法例第571W章证券及期货(稳定价格)规则第9(2)条，公司宣布，有关全球发售的稳定价 格期间已于2026年1月22日(星期四)(即提交香港公开发售申请的截止日期后第30日)结束。 超额配发股份将由公司按每股股份73.80港元(即全球发售项下每股股份的发售价，不包括1%经纪佣金、 0.0027%证监会交易徵费、0.00565%联交所交易费及 0.00015%会财局交易徵费)发行及配发。超额配发 股份将用于促成向已同意延迟交付其根据全球发售于国际发售中认购的部分H股的承配人交付相关H 股。公司将自发行超额配发股份收取额外所得款项净额约2.25亿港元(经扣除公司就部分行使超额配股 权应付的包销费用以及佣金及估计开支)。 联交所已批准超额配发股份上市及买卖。超额配发股份预期于2026年1月29日(星期四)上午九时正开始 于联交所主板上市及买卖。 智通财经APP讯，卧安机器人(06600)发布公告，公司宣布，招股章程所述的超额配股权已于2026年1月 22日(星期四)获整体协调人(为其本身及代表国际包销商)部分行使，涉及合共313.38万股股份(超额配发 股份)，约占于任何超额配股权获行使前全球发售项下 ...